Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
Gilead Sciences, Inc. (GILD) Jefferies Global Healthcare Conference Transcript
03:02pm, Wednesday, 07'th Jun 2023
Gilead Sciences, Inc. (NASDAQ:GILD ) Jefferies Global Healthcare Conference June 7, 2023 11:00 AM ET Company Participants Johanna Mercier - Chief Commercial Officer Conference Call Participants Michae
3 Biotech Stocks That Could Skyrocket in the Next 12 Months
08:55am, Wednesday, 07'th Jun 2023
Navigating the turbulent waters in the biotech space is no mean feat. With the sector's inherent volatility due to testing clinical trials and regulatory hurdles, the road toward market approval can b
U.S. Wide-Moat Stocks On Sale - The June 2023 Heat Map
12:25pm, Tuesday, 06'th Jun 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of th
Gilead (GILD), Arcus Announce Results From Mid-Stage NSCLC Study
04:11pm, Monday, 05'th Jun 2023
Gilead (GILD) and Arcus announce data from the interim analysis of the mid-stage ARC-7 study on domvanalimab in the NSCLC study.
3 Dividend Stocks You Can Buy Without Any Hesitation
06:14am, Saturday, 03'rd Jun 2023
Bristol Myers Squibb is a biopharmaceutical industry stalwart that pays a high dividend. Gilead Sciences' valuation is cheap, and its dividend continues to grow.
Gilead: Pharma Play Worth Watching On Multitude Of ASCO Data Readouts
07:11pm, Wednesday, 31'st May 2023
Gilead Sciences, Inc. is expected to offer 30 Abstract Presentations at the ASCO 2023 medical meeting to be held between June 2 - 6 of 2023. Product sales of Trodelvy increased by 52% to $222 million
2 Large Cap Biotech Stocks To Watch Right Now
04:29pm, Wednesday, 31'st May 2023
Large-cap biotech stocks to check out in the stock market today.
Gilead's (GILD) Veklury Gets Positive CHMP View for Extended Use
11:35am, Friday, 26'th May 2023
Gilead (GILD) obtains positive opinion for the use of Veklury in COVID-19 patients with severe renal impairment, including those on dialysis, from the European Medicines Agency's CHMP.
Gilead Sciences to Present at Upcoming Investor Conference
04:05pm, Thursday, 25'th May 2023
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #GILD--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference: Jefferies Healthcare Confe
3 Relatively Safe Stocks to Buy if a Recession Is on the Way
06:14am, Saturday, 20'th May 2023
AbbVie's current headwinds are only temporary. Gilead Sciences' business remains rock-solid.
3 Analyst Upgrades That Smart Investors Won't Ignore
01:29pm, Wednesday, 17'th May 2023
Even the most experienced investors have only so many hours in the day to perform their due diligence. That's where analyst ratings can be helpful.
GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?
10:22am, Tuesday, 16'th May 2023
Gilead Sciences (NASDAQ: GILD ) stock is a hot topic on Tuesday as a new price prediction builds enthusiasm among investors. BMO Capital Markets analyst Evan David Seigerman is behind today's news as
Gilead Sciences, Inc. (GILD) Presents at BofA Securities 2023 Health Care Conference (Transcript)
07:10pm, Saturday, 13'th May 2023
Gilead Sciences, Inc. (NASDAQ:GILD ) BofA Securities 2023 Health Care Conference May 9, 2023 2:20 PM ET Company Participants Andy Dickinson - CFO Conference Call Participants Geoff Meacham - Bank of A
Gilead Sciences Stock: Bear vs. Bull
05:30am, Friday, 12'th May 2023
Declining sales of certain drugs, including coronavirus treatment Veklury, has weighed on Gilead's earnings. Still, Gilead is the world's leader in HIV treatments -- and new products across treatment
